Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014)

Updated

Akebia Therapeutics (AKBA) recorded Preferred Dividend Payments of $86.9 million in FY2014, up 55.5% from $55.89 million in FY2013.

Analysis

Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014) Analysis & Trends

  • Per Business Quant data, AKBA's Preferred Dividend Payments was $55.89 million in FY2013 and $3.32 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -1,000.00
Jun 30, 2014 1,000.00
Mar 31, 2014 86.90 Mn
Dec 31, 2013 3.02 Mn
Sep 30, 2013 2.75 Mn
Jun 30, 2013 49.27 Mn
Mar 31, 2013 848,125.00
API Access

Akebia Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=AKBA&period=max&api_key=YOUR_API_KEY